Therapeutic approach to Crohn disease: possible parallels with hidradenitis suppurativa

Actas Dermosifiliogr. 2016 Sep:107 Suppl 2:2-7. doi: 10.1016/S0001-7310(17)30002-9.
[Article in English, Spanish]

Abstract

The current controversy in the setting of dermatology surrounding the treatment of inflammatory diseases, and specifically hidradenitis suppurativa, bears strong similarities with the debate concerning inflammatory bowel disease (IBD) that took place several years ago. That debate led to new perspectives on this disease and, in particular, its treatment after the development of biological agents.

Keywords: Anti-TNF; Biological agents; Crohn disease; Enfermedad de Crohn; Fármacos biológicos; Hidradenitis suppurativa; Hidradenitis supurativa; Inflamación; Inflammation; Multidisciplinar; Multidisciplinary.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Biological Factors / therapeutic use
  • Combined Modality Therapy
  • Crohn Disease / complications
  • Crohn Disease / pathology
  • Crohn Disease / therapy*
  • Cutaneous Fistula / drug therapy
  • Cutaneous Fistula / etiology
  • Cutaneous Fistula / surgery
  • Digestive System Fistula / drug therapy
  • Digestive System Fistula / etiology
  • Digestive System Fistula / surgery
  • Digestive System Surgical Procedures
  • Disease Management
  • Disease Progression
  • Drainage
  • Hidradenitis Suppurativa / pathology
  • Hidradenitis Suppurativa / therapy*
  • Humans
  • Proctitis / drug therapy
  • Proctitis / etiology
  • Proctitis / surgery
  • Remission Induction
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Biological Factors
  • Tumor Necrosis Factor-alpha